Clinical and Molecular Hepatology

"Eun Ji Jang"

Reply to correspondence on “Molecular classification of hepatocellular carcinoma based on zoned metabolic feature and oncogenic signaling pathway”: Eun Ji Jang, Pil Soo Sung; Clin Mol Hepatol 2026;32(1):e115-e116.
Published online May 13, 2025; DOI: https://doi.org/10.3350/cmh.2025.0498

Editorial

A novel link between tumor cell metabolism and patient prognosis: Editorial on “Molecular classification of hepatocellular carcinoma based on zoned metabolic feature and oncogenic signaling pathway”: Eun Ji Jang, Pil Soo Sung; Clin Mol Hepatol 2026;32(1):420-422.
Published online April 16, 2025; DOI: https://doi.org/10.3350/cmh.2025.0395

Citations

Citations to this article as recorded by

Correspondence to editorial on “Molecular classification of hepatocellular carcinoma based on zoned metabolic feature and oncogenic signaling pathway”
Tomoko Aoki, Naoshi Nishida, Masatoshi Kudo
Clinical and Molecular Hepatology.2026; 32(1): e79. CrossRef
Reply to correspondence on “Molecular classification of hepatocellular carcinoma based on zoned metabolic feature and oncogenic signaling pathway”
Eun Ji Jang, Pil Soo Sung
Clinical and Molecular Hepatology.2026; 32(1): e115. CrossRef
Clinical Prediction of Glycolysis-Driven Molecular Subclass of Hepatocellular Carcinoma without Transcriptomic Profiling
Tomoko Aoki, Masatoshi Kudo, Satoshi Ogiso, Genki Okumura, Megumi Hoshino, Yuka Nakamura, Ryo Morisue, Shohei Koyama, Naoshi Nishida, Kohei Hanaoka, Kazuko Sakai, Yutaka Kurebayashi, Masakatsu Tsurusaki, Masahiro Morita, Atsushi Takebe, Takaaki Murase, Ke
Liver Cancer.2026; : 1. CrossRef
Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography: A Potential Imaging Biomarker for Predicting Response to Combination Immunotherapy in Hepatocellular Carcinoma
Masatoshi Kudo
Liver Cancer.2025; 14(5): 511. CrossRef